Format

Send to

Choose Destination
See comment in PubMed Commons below
Obstet Gynecol. 2008 Aug;112(2 Pt 1):320-4. doi: 10.1097/AOG.0b013e31817e8acc.

Inherited thrombophilia and pregnancy complications revisited.

Author information

1
Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. mrodger@ohri.ca

Erratum in

  • Obstet Gynecol. 2008 Dec;112(6):1392. Claire, McLintock [corrected to McLintock, Claire].

Abstract

Inherited thrombophilias are not yet established as a cause of placenta-mediated pregnancy complications, such as fetal growth restriction, preeclampsia, abruption, and pregnancy loss. An inherited thrombophilia is only one of many factors that lead to development of these diseases and is unlikely to be the unique factor that should drive management in subsequent pregnancies. The paucity of evidence for benefit, coupled with a small potential for harm, suggests that low molecular weight heparin should be considered an experimental drug for these indications until data from controlled trials are published. At present, women with a history of placenta-mediated pregnancy complications, with or without a thrombophilia, should be followed closely without routine prophylactic low molecular weight heparin other than for prevention of venous thromboembolism in limited circumstances.

PMID:
18669729
DOI:
10.1097/AOG.0b013e31817e8acc
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Loading ...
    Support Center